|
DNAJC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.26349999971265E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.584700E-04 |
| Normal-vs-Stage2 |
1.79042999999268E-05 |
| Normal-vs-Stage3 |
4.25580004570492E-09 |
| Normal-vs-Stage4 |
2.13889999999273E-05 |
| Stage1-vs-Stage2 |
3.963600E-02 |
| Stage1-vs-Stage3 |
1.015500E-03 |
| Stage1-vs-Stage4 |
9.922000E-02 |
| Stage2-vs-Stage3 |
8.898800E-01 |
| Stage2-vs-Stage4 |
5.580400E-01 |
| Stage3-vs-Stage4 |
3.531000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.48609999756277E-08 |
| Normal-vs-AfricanAmerican |
4.221800E-01 |
| Normal-vs-Asian |
2.762200E-01 |
| Caucasian-vs-AfricanAmerican |
1.414380E-04 |
| Caucasian-vs-Asian |
4.006600E-01 |
| AfricanAmerican-vs-Asian |
5.302600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.5068999976472E-08 |
| Normal-vs-Female |
4.847700E-04 |
| Male-vs-Female |
2.645700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.658000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.00009999998352E-06 |
| Normal-vs-Age(61-80Yrs) |
9.85689999954964E-07 |
| Normal-vs-Age(81-100Yrs) |
2.384600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.354600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.885600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.302800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.413400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.740200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.628600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.506000E-01 |
| Normal-vs-Grade 2 |
2.08689999999789E-05 |
| Normal-vs-Grade 3 |
9.30239999474836E-08 |
| Normal-vs-Grade 4 |
1.985600E-04 |
| Grade 1-vs-Grade 2 |
1.347630E-01 |
| Grade 1-vs-Grade 3 |
4.385800E-02 |
| Grade 1-vs-Grade 4 |
1.152170E-01 |
| Grade 2-vs-Grade 3 |
2.313800E-01 |
| Grade 2-vs-Grade 4 |
9.359000E-01 |
| Grade 3-vs-Grade 4 |
3.206400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.51810050378288E-10 |
| Normal-vs-ccB subtype |
3.000000E-04 |
| ccA subtype-vs-ccB subtype |
1.524300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.07370000007801E-07 |
| Normal-vs-N1 |
5.469800E-01 |
| N0-vs-N1 |
4.709600E-02 |
|
|
